Stay updated on Flotetuzumab in PIF/ER AML Clinical Trial
Sign up to get notified when there's something new on the Flotetuzumab in PIF/ER AML Clinical Trial page.

Latest updates to the Flotetuzumab in PIF/ER AML Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoNo Change Detected
- Check21 days agoChange DetectedThe page now shows a newer revision version (v3.5.4) replacing the previous v3.5.3, indicating an update to the page version without altering the underlying study data.SummaryDifference0.0%

- Check28 days agoNo Change Detected
- Check43 days agoChange DetectedThis updates the ClinicalTrials.gov site’s displayed release/version from **v3.5.2** to **v3.5.3** without changing any study content.SummaryDifference0.0%

- Check50 days agoChange DetectedPage revision updated from v3.5.0 to v3.5.2.SummaryDifference0.0%

- Check79 days agoChange DetectedRevision: v3.5.0 added and v3.4.3 removed.SummaryDifference0.0%

- Check86 days agoChange Detected- Revision tag updated from v3.4.2 to v3.4.3 on the page. This appears to be a minor maintenance update and does not affect the study information presented.SummaryDifference0.0%

- Check114 days agoChange DetectedAdded Revision: v3.4.2; deleted the government funding lapse notice and Revision: v3.4.1, representing administrative site updates. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

Stay in the know with updates to Flotetuzumab in PIF/ER AML Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Flotetuzumab in PIF/ER AML Clinical Trial page.